Highbridge Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Highbridge Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-24,621	Closed	-$3.61M	–	1776
2014 Q4	$2.83M	Sell	24,621 -34,029	-58%	-$4.12M	0.04%	402
2014 Q3	$9.16M	Buy	58,650 +56,416	+2,525%	+$8.18M	0.12%	214
2014 Q2	$276K	Sell	2,234 -99,345	-98%	-$11M	﹤0.01%	898
2014 Q1	$10.5M	Buy	+101,579	New	+$10.4M	0.13%	180
2013 Q4	–	Sell	-12,603	Closed	-$843K	–	1546
2013 Q3	$843K	Sell	12,603 -141,887	-92%	-$9.78M	0.01%	719
2013 Q2	$10.2M	Buy	+154,490	New	+$8.83M	0.1%	227

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Highbridge Capital Management's SLXP Position: Q1 2015 in Review

Highbridge Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 24,621 shares — an estimated $3.61M sold.

Highbridge Capital Management first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $10.5M in Q1 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Highbridge Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Highbridge Capital Management sold 24,621 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $3.61M.
Highbridge Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 6 quarters.
Highbridge Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $10.5M in Q1 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Highbridge Capital Management's 13F filing for Q1 2015, filed 15 May 2015.